GRA_Logo

 + Home + About Us + Contact Us
 
+ Drug Delivery   + Monitoring & Diagnostics   + Healthcare    + Therapeutics    + Wound Care
 
Autoinjectors to 2016
Devices, Therapeutics, Markets, Strategies and Prospects


About This Report

Price: US$2,850

Publication: May 2012

Product Code: NKT456R




While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.
Highlights

· Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments

· Analyzes design factors, material selection issues, technologies and market development issues

· Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

· Charts market data and forecasts to 2016
Table of Contents
Executive Summary

Injectable Drug Delivery Market Dynamics

The Economics of Injectable Drugs
What’s Driving the Growth in Autoinjectors?
Prefilled Syringes Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors

Autoinjectors – Commercial Devices

Manual injection Autoinjectors
Automated Injection Autoinjectors
Reusable Autoinjectors
Disposable Autoinjectors
Bundled (Pre-assembled) Autoinjectors
Product Specific Autoinjectors

Autoinjector Device Design Factors

Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics

Autoinjector Drug Delivery – Key Therapeutic Sector Analysis

Anticoagulants
Autoimmune Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis
Emergency Medicine
Hepatitis
Hematopoietics
Hormones
Reproductive Health

Market Factors

Regulatory Issues
Device Branding
Patient Compliance
Healthcare Economics
Ease of Use

Autoinjector Devices - Company Profiles




 

 

Recent Research

Prefilled Syringes to 2016

Drug Self-Administration Markets to 2016

Therapeutic Proteins to 2016


Events

American Association for Clinical Chemistry (July 2012)

World Congress on Glucose Monitoring and Insulin Delivery (April 2012)

 
     
 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2011 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career